How do women’s substance use problems, needs and outcomes differ from those of men? To mark International Women’s Day 2020, a collection of interventions that further our understanding of how sex and gender can influence the course of addiction and treatment, with a particular focus on women starting with the analyses most recently added or updated, totalling today 72 documents.
Click blue titles to view full text in a new window
Use the selectors at the bottom to turn to the next page in the list of documents
REVIEW 2016 HTM file
Buprenorphine versus methadone for opioid dependence in pregnancy
Among pregnant women, substitute prescribing is preferable to continued illicit opioid use and supervised withdrawal. Buprenorphine has different properties to the dominant treatment option methadone, but both stand to improve pregnancy and infant outcomes.
Part review, part ‘call to action’, the featured paper highlights the lack of awareness of evidence-based interventions for transgender people, and advocates for ‘culturally-sensitive’ approaches embedded in both general and specialised substance use programmes.
REVIEW 2008 HTM file
Substance abuse treatment for women offenders: a research review
A major contributing factor to women being incarcerated and a critical factor in women’s reoffending, this review addresses the substance use treatment needs of female offenders and gender-specific interventions.
With an ‘alarmingly scarce’ evidence base to go on, the researchers draw parallels with the broader alcohol treatment literature, finding some support for interventions with motivational components among cohorts of gay and bisexual men, for whom heavy drinking is associated with more severe and chronic consequences.
Compared to brief advice, the CHOICES Plus intervention significantly lowered the risk of alcohol- and tobacco-exposed pregnancies among women in a low-income primary care population. This US-based trial illustrates the efficacy of a bundle of ‘pre-conception’ services for risky drinking, smoking, and ineffective contraception.
Strongest support for ‘therapeutic community’ approach to incarceration-based drug treatment according to robust review of evidence – with consistent reductions found in both drug relapse and recidivism.
STUDY 2012 HTM file
An evaluation of the Option 2 intensive family preservation service
In Wales Option 2 works intensively over a few weeks with substance using parents whose children are at serious risk – serious enough for imminent care proceedings. This second evaluation confirmed that the cost-saving service helps keep children with their families without inadvertently harming the children.
REVIEW 2010 HTM file
Gender issues in the pharmacotherapy of opioid-addicted women: Buprenorphine
This paper reviews the treatment options for women dependent on opiate-type drugs, focussing on buprenorphine, including its safety for the treatment of pregnant and breastfeeding women.
A computer-delivered brief intervention plus booster mailings increased the alcohol abstinence rate and improved pregnancy outcomes among risky drinking pregnant women recruited at a US antenatal clinic, though in this small pilot trial the results were not statistically significant.
After intensive coaching in parenting conducted with mother and child together, randomly selected mothers in residential treatment demonstrated more sensitive parenting than mothers not allocated to the programme, promising to intercept inter-generational transmission of poor parenting.
Select search results pagePREVIOUS | NEXT 1 2 3 4 5 6 7 8